作者: Andrea Huwiler , Josef Pfeilschifter , Holger Stark , Aleksandra Zivkovic
DOI:
关键词: Biochemistry 、 Biology 、 Sphingolipid
摘要: The present invention relates to new heterocyclic compounds as modulators of sphingolipid signaling and uses thereof pharmaceutically active agents, suitable for treating proliferative, degenerative, infectious, other diseases.